Queen's Medical Center

This study tested whether a drug called tocilizumab could help adults hospitalized with severe COVID-19 pneumonia. The goal was to see if the drug, which calms an overactive immune system, could improve patients' health status and reduce the need for breathing support compared to…

This study aimed to see if adding the drug hydroxychloroquine to standard hospital care helped adults with COVID-19 get better faster. It compared patients who received the drug for five days to those who received only usual care. The trial was stopped early after enrolling only …